EGFR and small cell carcinoma: The triplex can then bind both the CCAT1 promoter, determining its transcription, and the super-enhancer domains of epidermal growth factor receptor (EGFR), thus activating downstream MAPK signaling cascade with the effect of promoting small cell carcinoma tumorigenesis [22,23].